Search Results

Global Partnership to Fund Groundbreaking Research in Treatment of Multiple Myeloma

Groundbreaking research aimed at translating novel chimeric antigen receptor (CAR) T-cell therapies into improved treatment for multiple myeloma is th…

News Release

First 2025 New Blood Cancer Drug Approval Adds Years of Life for People Living with Mantle Cell Lymphoma

Mantle cell is an aggressive form of non-Hodgkin lymphoma Rye Brook, N.Y., January 17, 2025 – Acalabrutinib (Calquence®) is the first ever FDA-approve…

News Release

FDA’s Recent Approval of 2 CAR T-Cell Therapies a ‘Big Step Toward’ Long-Term Control of Myeloma for More Patients

The FDA has approved cilta-cel (Carvykti™) and ide-cel (Abecma®) for earlier treatment of multiple myeloma.Rye Brook, N.Y., April 16, 2024 – The U.S. …

News Release

FDA’s ODAC Endorses New Indications for 2 CAR-T Therapies for Myeloma

Rye Brook, N.Y., March 15, 2024 – Today’s vote by the FDA’s Oncologic Drugs Advisory Committe (ODAC), a group of independent cancer experts, stating t…

News Release

FDA Expands Use of Leukemia Treatment to Include Children

LLS supported the very first antibody-drug conjugate gemtuzumab ozogamicin, which targets CD33, and was approved in 2000 to treat acute myeloid leukem…

News Release

FDA Approves Treatment for Myelofibrosis and Anemia

Rye Brook, N.Y., September 29, 2023 – The U.S. Food and Drug Administration (FDA) recently approved momelotinib (Ojjaara™) for use in adults with inte…

News Release

FDA Approves Targeted Therapy for Patients with Newly Diagnosed Multiple Myeloma

LLS was an early funder of research that identified the CD38 protein as a target for blood cancer treatment Rye Brook, N.Y., October 31, 2024 – The U…

News Release

FDA Approves Targeted Immunotherapy for Aggressive Forms of Follicular Lymphoma

Epcoritamab works by engaging the immune system to kill cancer cells Rye Brook, N.Y., June 27, 2024 – The U.S. Food and Drug Administration (FDA) on W…

News Release

FDA Approves New Treatment for Adults with Chronic Myeloid Leukemia

Asciminib provides another option to help CML patients live longer, healthier lives Rye Brook, N.Y., December 6, 2024 – The U.S. Food and Drug Adminis…

News Release

FDA Approves a New Immune-Based Treatment Option for People with Mantle Cell Lymphoma

The FDA continues to expand availability of breakthrough CAR T-cell immunotherapy to benefit more blood cancer patientsRye Brook, N.Y., May 31, 2024 –…

News Release

Ella

Meet Ella. Lymphoma survivor. All-star cheerleader. Ella's first symptoms, at age 2 1/2, had all the indications of child abuse, until doctors discove…

FDA Approves New Targeted Treatment for Acute Myeloid Leukemia

no-float 100 Rye Brook, N.Y., July 25, 2023 – The U.S. Food and Dr…

News Release

The Follicular Lymphoma Foundation Joins Forces With The Leukemia & Lymphoma Society to Bring Hope to Those Living With Follicular Lymphoma

no-float 100 AUGUST 7, 2023 - The Follicular Lymphoma Foundation (…

Research: Grants

The Leukemia & Lymphoma Society and Blood Cancer UK Team Up to Award $4.25M for Research into Ways to Prevent Leukemia

RYE BROOK, N.Y., February 5, 2024 — The Leukemia & Lymphoma Society (LLS) and Blood Cancer UK announced today a five-year, $4.25 million grant to laun…

News Release

The Leukemia & Lymphoma Society Honors 6 Scientists for their Contributions to Blood Cancer Research at Event During American Society of Hematology Annual Meeting

no-float 100 San Diego, December 9, 2024 – Using the latest cuttin…

News Release

Shred For Red: Communities Nationwide to Join Olympians at Deer Valley Resort to Support Blood Cancer Patients

no-float 100 (RYE BROOK, N.Y., November 12, 2024) - The Leukemia &…

News Release

Skies Across North America to Light Up This Fall in Support of Blood Cancer Patients

no-float 100 The Leukemia & Lymphoma Society kicks off philanthrop…

News Release

The Leukemia & Lymphoma Society Honors Five Outstanding Blood Cancer Scientists with 2023 Awards

RYE BROOK, N.Y., December 11, 2023 – The Leukemia & Lymphoma Society (LLS) recognized and celebrated the outstanding contributions of five scientific …

News Release